U.S. Senator Elizabeth Warren | Warren Urges FTC to Prote...
In October 2024, Senator Elizabeth Warren (D-Mass.) urged the FTC to closely scrutinize the Novo Nordisk-Catalent merger and to block it if it violated antitrust law.
U.S. Senator Elizabeth Warren | Warren Calls on FTC to Cl...
Jan 26, 2023 · Washington, D.C. – U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan and FTC Commissioners Alvardo Bedoya and Rebecca Kelly Slaughter urging the agency to closely scrutinize two pending big pharmaceutical mergers: Amgen and Horizon Therapeutics, and Indivior and Opiant.
U.S. Senator Elizabeth Warren | Warren Urges FTC To Close...
Oct 10, 2024 · Washington, DC – U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, and block the deal if it is found to be illegal under antitrust law.
FTC Noncompete Ban Draws Strong Backing From Democrats
Apr 19, 2023 · Led by Sens. Elizabeth Warren (Mass.) and Richard Blumenthal (Conn.) in the Senate, the lawmakers urged the FTC to stand strong and “resist calls” from businesses to postpone the rule or add carveouts and instead “act quickly to …
Warren wants close FTC scrutiny of drug distributors buying …
Oct 29, 2024 · Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize recent deals from McKesson and Cardinal Health to buy oncology practices, saying those transactions pose...
Warren tells FTC she is "particularly concerned" about Amgen and ...
Jan 26, 2023 · Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.
Warren slams legal challenges to FTC noncompete ban - TechTarget
Aug 1, 2024 · Sen. Elizabeth Warren (D-Mass.) voiced her support for the Federal Trade Commission's ban on noncompete agreements and said she believes ongoing legal efforts to roll back the rule are wrong. The ban, which is set to take effect Sept. 4, has so far faced legal challenges in Texas and Pennsylvania.
Warren calls on the FTC to scrutinize to Big Pharma mergers
Jan 30, 2023 · Late last week, Massachusetts Sen. Elizabeth Warren called on the Federal Trade Commission (FTC) to put a magnifying glass on a pair of pending Big Pharma mergers.
Sen. Elizabeth Warren wants FTC to scrutinize Novo Nordisk deal …
Oct 10, 2024 · Sen. Elizabeth Warren (D-MA) is calling on the Federal Trade Commission to carefully evaluate Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE: CTLT).
Elizabeth Warren Wants FTC Review Of Primary Care Deals, But
Mar 23, 2023 · News that U.S. Sen. Elizabeth Warren wants the Federal Trade Commission to review the parade of acquisitions by retailers and health insurers of primary care companies, could slow...